(Q53470792)
Statements
Phase II trial of sorafenib plus interferon alfa-2b as first- or second-line therapy in patients with metastatic renal cell cancer. (English)
1 reference
W Kimryn Rathmell
1 reference
Jared A Gollob
1 reference
Tina M Richmond
1 reference
Christine B Marino
1 reference
Elizabeth K Miller
1 reference
Gayle Grigson
1 reference
Catharine Watkins
1 reference
Lin Gu
1 reference
Bercedis L Peterson
1 reference
John J Wright
1 reference
1 August 2007
1 reference
25
1 reference
22
1 reference
3288-3295
1 reference
Identifiers
1 reference